Photo from alchemab.com ↗Profile · alchemab.com ↗

Jane Osbourn

Founder

Now Founder, Alchemab Therapeutics

Latest on AI4S.fyiFunding · Jul 9 · founderAlchemab Therapeutics · Series A extension · GBP 25M (the release gives $34M)

Photos come from each person's X account, their own site, lab or team page, a conference page that lists them as a speaker in the same role, or Wikimedia Commons under the licence credited, so some may be out of date. Anyone can ask for theirs to be replaced or removed. Contact →

Affiliations

Current

Founder · Alchemab Therapeuticssince 2019alchemab.com ↗

Current roles come from these dated records, not from the bio below. Each links the page it was read from.

Founded

Alchemab TherapeuticsDrug discovery · 2019 · 2 rounds on record · disclosed $32M · Series A extension GBP 25M (the release gives $34M)

On the timeline

2026-07-09Alchemab, which looks for antibodies in people who resist disease, adds a GBP 25M Series A extension from the British Business Bank, the bank's largest life sciences investment

Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →